Bacteria-killing protein could lead to a new treatment for diabetes
24 February 2016 | By Victoria White
Researchers have discovered that the protein cathelicidin antimicrobial peptide helps the pancreas regenerate and produce insulin...
List view / Grid view
News
Avacta to develop Affimer reagents to reduce use of animals in research
Avacta is to develop inhibin Affimer inhibitors. Inhibition of this protein stimulates the production of greater numbers of embryos per mouse...
DNA origami successfully used to kill leukaemia cells
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
OncoQR ML’s TYG100 induces strong immune response in pancreatic cancer
23 February 2016 | By Victoria White
In a highly relevant non-human primate model TYG100 was able to induce a strong and clinically relevant immune response...
Plasticell and Pierre Fabre in brown fat enhancement collaboration
23 February 2016 | By Victoria White
Plasticell and Pierre Fabre are to work together to discover plant-based products that enhance the metabolic function of brown adipose tissue...
Desktop Genetics receives grant for site-specific epigenetic CRISPR editing
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
Pherecydes Pharma appoints Fanneau de La Horie as CEO
22 February 2016 | By Katie Sadler
Pherecydes Pharma has announced the appointment of Guy-Charles Fanneau de La Horie, MBA as its new Chief Executive Officer.
Researchers use key mechanism to treat autoimmune diseases
19 February 2016 | By Victoria White
The discovery could change the way researchers understand and treat autoimmune diseases such as type 1 diabetes and multiple sclerosis...
Suppressing JNK3 could reduce severity of spinal muscular atrophy
19 February 2016 | By Victoria White
In a study, mice with spinal muscular atrophy saw great improvement when the JNK3 enzyme was genetically inhibited to eliminate its activity...
New nanoparticle has potential to treat ocular cancer
19 February 2016 | By Victoria White
Researchers have developed a new nanoparticle that uses a tumour cell's protective mechanism against itself - short-circuiting tumour cell metabolism and killing tumour cells...
Select Biosciences Second Annual Organ-on-a-Chip World Congress and 3D-Culture, July 7-8, 2016, Boston, USA.
18 February 2016 | By Select Biosciences
Select Biosciences is organizing its 2nd Annual World Congress focusing on Organs-on-Chips—an extremely important and cutting-edge field of important in basic research as well as pharmaceutical discovery and development...
Discover the latest developments in Organ-on-a-Chip
18 February 2016 | By SELECTBIO
SELECTBIO is delighted to announce Organ-on-a-Chip Europe 2016, which will be held on 5 - 6 April in Cambridge, UK...
MERS treatment demonstrates promising results in mice
18 February 2016 | By Victoria White
The treatment - an antibody that blocks the MERS virus - was produced by cows that had been genetically modified to mimic certain aspects of the human immune system...
Studies suggest major role for Regen’s NR2F6 target in controlling key immune functions
18 February 2016 | By Victoria White
The results demonstrate that suppression of NR2F6 in T-cells results in increased expression of key immune stimulatory proteins IL-17 and IL-18...
Scientists discover bird blood cell which destroys C. neoformans
17 February 2016 | By Victoria White
Cryptococcus neoformans is a fungus that causes fatal infections in humans with a weakened immune system...
